Cheri Walker
President at Firefly BioWorks, Inc.
Profile
Cheri Walker has held positions as President & Director at Firefly BioWorks, Inc. and Director at Brickbio, Inc.
Cheri Walker active positions
Companies | Position | Start |
---|---|---|
Brickbio, Inc.
Brickbio, Inc. Packaged SoftwareTechnology Services Brickbio, Inc. operates as a bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins. The company was founded by John Boyce and James Italia and is headquartered in Woburn, MA. | Director/Board Member | - |
Firefly BioWorks, Inc.
Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Firefly BioWorks, Inc.
Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Brickbio, Inc.
Brickbio, Inc. Packaged SoftwareTechnology Services Brickbio, Inc. operates as a bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins. The company was founded by John Boyce and James Italia and is headquartered in Woburn, MA. | Technology Services |
- Stock Market
- Insiders
- Cheri Walker